Home
>
National Drug Code (NDC)
>
Lexapro
Lexapro - 55154-4620-2 - (Escitalopram oxalate)
Drug Information of Lexapro
| Product NDC: | 55154-4620 |
| Proprietary Name: | Lexapro |
| Non Proprietary Name: | Escitalopram oxalate |
| Active Ingredient(s): | 20 mg/1 & nbsp; Escitalopram oxalate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lexapro
| Product NDC: | 55154-4620 |
| Labeler Name: | Cardinal Health |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021323 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20020814 |
Package Information of Lexapro
| Package NDC: | 55154-4620-2 |
| Package Description: | 4800 TABLET in 1 BOTTLE, PLASTIC (55154-4620-2) |
NDC Information of Lexapro
| NDC Code | 55154-4620-2 |
| Proprietary Name | Lexapro |
| Package Description | 4800 TABLET in 1 BOTTLE, PLASTIC (55154-4620-2) |
| Product NDC | 55154-4620 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Escitalopram oxalate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20020814 |
| Marketing Category Name | NDA |
| Labeler Name | Cardinal Health |
| Substance Name | ESCITALOPRAM OXALATE |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |
